Organisations can apply for a share of £35 million to develop new vaccines against infectious diseases
Award: Up to £3m
Opens: 23rd Jan 2017
Closes: 19th Apr 2017
This competition aims to support the clinical development of candidate vaccines against 12 diseases. The UK Vaccine Network has identified these diseases as a priority because they have the potential to cause epidemics in low- and middle-income countries (LMICs).
The competition will support the clinical development of candidate vaccines up to and including phase IIb trials. The funders will also consider co-funding phase III trials, either with industry or other philanthropic or government funders.
The competition funders are particularly keen to support:
Funding and project details
The competition is a single stage. It covers carrying out clinical development of vaccines up to and including phase IIb trials.
This competition is aimed at supporting candidate vaccines that are ready for, or close to moving into phase I clinical trials. This can include good laboratory practice toxicology or manufacturing activity to support the proposed clinical trial.
Applicants must describe the candidate vaccine or vaccine platform technology they are developing.
They should give details of its: